REVIEW
Published on 07 Jan 2026
The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies
doi 10.3389/fonc.2025.1743689
- 386 views
- Frontiers in Surgery
- Surgical Oncology
- Research Topics
- Advances in Combined Modality Treatments for Prostate Cancer
Advances in Combined Modality Treatments for Prostate Cancer
2,341
Total downloads
18k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 01 Dec 2025
Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT–based comprehensive radiographic scheme and cognitive fusion targeted biopsy
doi 10.3389/fonc.2025.1721477
- 1,160 views
ORIGINAL RESEARCH
Published on 01 Oct 2025
Real-world multicenter study of rezvilutamide plus androgen deprivation therapy in Chinese patients with high-volume metastatic hormone-sensitive prostate cancer
doi 10.3389/fonc.2025.1657772
- 1,270 views
ORIGINAL RESEARCH
Published on 26 Sep 2025
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen
doi 10.3389/fonc.2025.1650378
- 1,577 views
CASE REPORT
Published on 27 Aug 2025
Case Report: Primary extraskeletal osteosarcoma in prostate
doi 10.3389/fonc.2025.1558053
- 1,004 views
REVIEW
Published on 25 Jul 2025
Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach
doi 10.3389/or.2025.1599292
- 4,843 views
CASE REPORT
Published on 23 Jul 2025
Prostate cancer inducing secondary linitis plastica of the rectum: a rare case report and literature review
doi 10.3389/fonc.2025.1597367
- 1,341 views
REVIEW
Published on 18 Jun 2025
Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
doi 10.3389/fimmu.2025.1583363
- 3,811 views
- 1 citation
Published in
Frontiers in Surgery
Surgical Oncology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: